Assessment of the oxidative stress markers in patients with chronic renal insufficiency undergoing dialysis treatment

Clinica Terapeutica

Volumn 161, Issue 5, 2010, Pages 441-444

  Coaccioli, Stefano ^a   Standoli, M L ^a   Biondi, R ^a   Panaccione, A ^a   Landucci, P ^a   Del Giorno, R ^a   Paladini, A ^b   Standoli, M ^c   Puxeddu, A ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c Santa Maria General Hospital   (Italy)

Author keywords

Chronic renal insufficiency; Hemodialysis; Oxidant antioxidant status; Oxidative stress

Indexed keywords

THIOL;

AGED; ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; D ROMS TEST; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; OXY ADSORBENT TEST; RENAL REPLACEMENT THERAPY; SHP TEST;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 78149297906     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Antonili F, Valente F, Ricciardi D, et al. Principal component analysis of some oxidative stress parameters and their relationship in hemodialytic and transplanted patients. Clin Chim Acta 2005; 35:887-94
2. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51:2-15 (Pubitemid 27064516)
3. Wratten ML, Tetta C, Ursini F, et al. Oxidant stress in hemodialysis: prevention and treatment strategies. Kidney Int 2000; 58(suppl 76): 126-32
4. Miyata T, Van Ypersele de Strihou C, Kurokawa K, et al. Alteration in nonenzymatic biochemistry in uraemia: origin and significance of "carbonylic stress" in long term uraemic complications. Kidney Int 1999; 55:389-99
5. Dean RT, Fu S, Stocker R, et al. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997; 324:1-18 (Pubitemid 27229359)
6. Stadtman ER, Levine RL. Proteine oxidation. Ann NY Acad Sci 2000; 899:191-208
7. Carrard G, Bulteau AL, Petropoulos I, et al. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 2002; 34(11):1461-74 (Pubitemid 35245402)
8. Shirai S, Ominato M, Shimazu T, et al. Imbalance between production and scavenging of hydroxyl radicals in patients maintained in hemodialysis. Clin Exp Nephrol 2005; 9(4):310-4
9. Shimazu T, Ominato M, Toyama K, et al. Effects of a vitamin E modified dialysis membrane on neutrophil superoxide anion radical production. Kidney Int Suppl 2001; 78:S137-43 (Pubitemid 32144086)
10. Drai J, Bannier E, Chazot C, et al. Oxidant and antioxidant in long term haemodialysis patients. Farmacother 2001; 56(5-7):463-5
11. Dursun E, Dursun B, Suleymanlar G, et al. Effect of haemodialysis on oxidative stress and antioxidants in diabetes mellitus. Acta Diabetol 2005; 42(3): 123-8 (Pubitemid 41551999)
12. Boaz M, Matas Z, Biro A, et al. Serum malondialdehyde and prevalent cardiovascular disease in hemodialys. Kidney Int 1999; 56(3): 1978-83 (Pubitemid 29411736)
13. Himmelfarb J, Stenvinkel P, Ikizler TA, et al. The elephant in uraemia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62(5): 1524-38
14. Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis in uremic hypertension. Kidney Int 1998; 53(6): 1748-54 (Pubitemid 28243760)
15. Hasdan G, Benchetrit S, Rashid G, et al. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int 2002; 61(2):586-90
16. Deng G, Vaziri ND, Jabbari B, at all. Increased tyrosine nitration of the brain in chronic renal insufficiency: reversal by antioxidant therapy and angiotensin-converting enzyme inhibition. J Am Soc Nephrol 2001; 12(9): 1892-9
17. Shainkin-Kestenbaum R, Caruso C, Berlyne GM. Reduced superoxide dismutase activity in erythrocytes of dialysis patients: a possible factor in the etiology of uremic anemia. Nephron 1990; 55(3):251-3
18. Nèmet I, Vargha I, Matkovics B, Dobos E. Erythrocyte defence mechanism against free oxygen radicals in haemodialysed uraemic children. Pediatr Nephrol 1991; 5:179-83
19. Coaccioli S, Panaccione A, Biondi R, et al. Evaluation of oxidative stress in rheumatoid arthritis and psoriatic arthritis and psoriasis. Clin Ter 2009; 160(6):467-72
20. Valentini J, Grotto D, Paniz C, et al. The influence of hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients Biomed Pharmacother 2008; 62(6):378-82, doi: 10.1016/j.biopha.2007.10. 017
21. Valko M, Izakovic M, Mazur M, et al. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266(1-2):37-56
22. Antolini F, Valente F, Ricciardi D, et al. Normalization of oxidative stress parameters after kidney transplant is secondary to full recovery of renal function Clin Nephrol 2004; 62(2): 131-7
23. Usberti M, Gerardi GM, Gazzotti RM, et al. Oxidative stress and cardiovascular disease in hemodialyzed patients. Nephron 2002; 91(1):25-33
24. Galli F, Canestrari F, Buoncristiani U. Biological effects of oxidant stress in haemodialysis: the possible roles of Vit E. Blood Purif 1999; 17(2-3):79-94
25. Dursun E, Ozben T, Süleymanlar G, et al. Effect of hemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med 2002; 40(10): 1009-13
26. Clermont G, Lecour S, Lahet J, et al. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res 2000; 47(3):618-23
27. Tielemans C, Husson C, Schurmans T, et al. Effects of ultrapure and non sterile dialysate on the inflammatory response during in vitro hemodialysis. Kidney Int 1996; 49:236-43
28. Ayus JC, Sheikh-Hamad D. Silent infection in clotted hemodialysis access grafts. J Am Soc Nephrol 1998; 9(7): 1314-7
29. Noris M, Benigni A, Boccardo P, et al.. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 1997; 51:294-300